Best of
Tirzepatide 12.5 mg: what it costs
Step 5 of the tirzepatide ladder, around weeks 17-20. 6 providers charge the same here as at the starting dose — the rest may not.
Updated 2026-09-18 · Prices verified independently
Each rung of this ladder means something different, and 12.5 mg is the one people ask about most at this stage.
12.5 mg is step 5 of 6 on the tirzepatide ladder, reached around weeks 17-20. A step between the two studied doses, used where 10 mg has been tolerated but has stopped producing change.
Because this is an early rung, the main cost question is not what 12.5 mg costs today but what happens when you reach the higher doses. Programmes that hold one price across the whole ladder are the ones that make that predictable.
What this page is for
Not to tell you which dose to be on — that is your prescriber's call. It is to explain what this particular rung is doing, what it tends to feel like, and what it will cost you, because on a lot of programmes those last two move together.
What 12.5 mg is for
12.5 mg is the least necessary rung on the ladder for most people. It exists for the case where 10 mg was tolerated well but has stopped producing change, and you want one more step before the maximum. Reaching it should be a deliberate clinical decision rather than the automatic next entry in a schedule — and a programme that escalates you here without asking how you are doing is telling you something about how it operates.
Escalating this far is a clinical decision rather than a default. Plenty of people never need it.
Where 12.5 mg sits on the ladder
| Step | Dose | Roughly when |
|---|---|---|
| 1 | 2.5 mg | weeks 1-4 |
| 2 | 5 mg | weeks 5-8 |
| 3 | 7.5 mg | weeks 9-12 |
| 4 | 10 mg | weeks 13-16 |
| 5 | 12.5 mg ← this page | weeks 17-20 |
| 6 | 15 mg | weeks 21+ |
Do you need to go higher than 12.5 mg?
Not necessarily. The ladder exists so that you can stop where the medication is working for you, and plenty of people settle below the maximum. Reaching the top dose is not a measure of success, and the trial figures are averages rather than targets.
Should I go from 10 mg straight to 15 mg?
That is a question for your prescriber, but the ladder exists precisely to avoid large jumps. 12.5 mg is there to make the last step gentler, and skipping it is how the final increase becomes unpleasant.
One last thing, because it applies to everything on this site: compounded medication is not FDA-approved, two approved pills now start around $149 a month, and eligible Medicare members can get certain GLP-1s for $50 from July 2026. Any of those may beat what you were about to buy.
Read next
- Flat pricing at every dose
Programmes where the price does not rise as your dose does — which matters more over a year than most advertised discounts.
- The cheapest tirzepatide online
Every provider whose monthly price actually includes the medication, sorted on what you are billed in month two.
- Tirzepatide 2.5 mg: what it costs
Step 1 of the tirzepatide ladder, around weeks 1-4. 6 providers charge the same here as at the starting dose — the rest may not.
- Tirzepatide 5 mg: what it costs
Step 2 of the tirzepatide ladder, around weeks 5-8. 6 providers charge the same here as at the starting dose — the rest may not.
- Medicare, GLP-1s and the $50 month
CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure